#Brazil #Switch Bioworks #nitrogen fertilizer #San Carlos #Programmable Microbes

Switch Bioworks Expands into Brazil with Regulatory Approval

Switch Bioworks, a pioneering biotechnology firm known for its innovative approach to programmable microbes, has made a significant breakthrough by receiving approval from Brazil's National Technical Biosafety Commission (CTNBio). This approval paves the way for the company to conduct field tests of its engineered nitrogen-fixing microbes in Brazil, one of the largest agricultural markets globally.

The significance of this approval cannot be understated, as Brazil is not only a major producer of key crops such as soybeans and corn but also boasts a sophisticated market for biological inputs. The country's unique growing seasons offer the potential for multiple harvests and learning cycles each year, which will significantly enhance the data generation and product development process for Switch Bioworks.

Background on Switch Bioworks

Founded as a spinout from Stanford University, Switch Bioworks specializes in creating genetic control systems that enable microbes to perform specific tasks. The company's innovative platform focuses on biological methods of nitrogen production, which traditionally relies on the energy-intensive Haber-Bosch process. This conventional method of producing nitrogen fertilizer is fraught with challenges including energy dependency and susceptibility to market fluctuations.

In contrast, Switch's biological technology offers a groundbreaking approach: utilizing engineered microbes that can fix nitrogen directly on plant roots. Laboratory studies have demonstrated that these programmable microbes can fix almost five times more nitrogen than traditional strains. This innovation addresses the pressing need for sustainable agricultural solutions, particularly as global demand for food grows.

The Role of Brazil

By entering the Brazilian market, Switch Bioworks aims to capitalize on the country's vast agricultural landscape and diverse soils, which vary significantly from those in other regions where the company operates, such as the United States and Kenya. The rigorous field trials in Brazil are expected to provide valuable insights into the performance of its microbial technology under different agricultural practices and environmental conditions.

Brazilian farmers often face volatility in nitrogen fertilizer pricing and supply, highlighting an urgent need for effective alternatives. The approval to use engineered microbes as a biological fertilizer could offer a more localized and resilient source of nitrogen, providing farmers with greater control and stability.

Expanding Global Footprint

Switch Bioworks is on an ambitious journey, having already established itself in the U.S. with approved field trials across six Midwest states, and in Kenya, where it is collaborating with local partners to test various microbial candidates in smallholder farming contexts. The addition of Brazil signifies an important step toward a more comprehensive portfolio of biofertilizer development, extending across three continents.

“What we are seeing in Brazil is an integration of world-class agricultural research, commercial scale, and farmer adoption,” said Tim Schnabel, founder and CEO of Switch Bioworks. “This approval provides us with a vital opportunity not only to showcase our technology but also to adapt and refine it in diverse agricultural environments. Each new testing site is a chance for us to enhance our learning and build on the infrastructure necessary for global deployment.”

The core technology of Switch Bioworks is protected by several patent families. As the company looks to the future, it envisions a world where the process of nutrient manufacturing extends beyond traditional factories to where these engineered microbes create what is needed, exactly where and when it is needed, making agricultural practices more sustainable and efficient.

Through providing insights that empower farmers with biological solutions, Switch Bioworks is well on its way to establishing a new frontier in agricultural biotechnology that could redefine how farmers engage with crop production worldwide.